Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Effectiveness Study of a Typhoid Conjugate Vaccine in Kisantu, Democratic Republic of Congo (TyVECO) - Step 2: Typhoid Conjugate Vaccine (TCV) Mass-vaccination Campaign

NCT05119426 is registered in ClinicalTrials.gov with International Vaccine Institute as lead sponsor.

NCT NCT05119426
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05119426 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Effectiveness Study of a Typhoid Conjugate Vaccine in Kisantu, Democratic Republic of Congo (TyVECO) - Step 2: Typhoid Conjugate Vaccine (TCV) Mass-vaccination Campaign
Lead sponsor
International Vaccine Institute
Phase
Phase 4
Overall status
Unknown status
Start date
February 11, 2022
Completion date
December 31, 2024
Enrollment
48,000 (estimated)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

typhoid fever